Skip to main content
SpringerLink
Log in

Clinical Magnetic Resonance Spectroscopy

  • Chapter
Recent Advances in Diagnostic Neuroradiology

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 231 Accesses

Abstract

Since the early days of the introduction of magnetic resonance as a clinical imaging modality, magnetic resonance spectroscopy (MRS) has been earmarked as a potentially useful clinical tool, able to provide biochemical information of tissues in a completely non-invasive way. The penetration of the technique into the daily clinical diagnosis has however been much slower than expected from the initial enthusiasm. Still, the progress is slow, is steady, and the quantity and reproducibility of data acquired in a number of pathologies are such that MRS is now being included as a diagnostic or of as a follow-up procedure in some examinations, as an essential adjunct to MRI and other imaging techniques (Danielsen and Ross 1998, Young and Cecil Charles 1996).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Achten E, Boon P, Van-De Kerckhove T et al. (1997) Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy. AJNR Am J Neuroradiol 18:1131–1139

    CAS  PubMed  Google Scholar 

  • Achten E, Santens P, Boon P et al. (1998) Single-voxel proton MR spectroscopy and positron emission tomography for lateralization of refractory temporal lobe epilepsy [see comments). AJNR Am J Neuroradiol 19:1–8

    CAS  PubMed  Google Scholar 

  • Alonso J, Rovira A, Capellades J et al. (1996) Cerebral proton spectroscopy of people infected with the human immunodeficiency virus. Med Clin Bare 107:361–365

    CAS  Google Scholar 

  • Arnold DL, Wolinsky JS, Matthews PM et al. (1998) The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry 64 Suppl 1:S94–101

    Google Scholar 

  • Aotsuka A, Shinotoh H, Hattori T (1997) Magnetic resonance spectroscopy in Parkinson’s disease and multiple system atrophy. Nippon Rinsho 55:249–254

    CAS  PubMed  Google Scholar 

  • Bartha R, Williamson PC, Drost DJ et al. (1997) Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 54:959–965

    CAS  PubMed  Google Scholar 

  • Bergman AJ, Van-der Knaap MS, Smeitink JA et al. (1996) Magnetic resonance imaging and spectroscopy of the brain in propionic acidemia: clinical and biochemical considerations. Pediatr Res 40:404–409

    CAS  PubMed  Google Scholar 

  • Berry I, Ranjeva JP, Duthil P et al. (1998a) Diffusion and perfusion MRI, measurements of acute stroke events and outcome: present practice and future hope. Cerebrovasc Dis 8 Suppl 2:8–16

    Google Scholar 

  • Berry I, Ranjeva JP, Manelfe C et al. (1998b) Magnetic resonance imaging of multiple sclerosis lesions. Rev Neurol (Paris) 154:607–617

    CAS  PubMed  Google Scholar 

  • Bertolino A, Callicott JH, Elman I et al. (1998a) Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 43:641–648

    CAS  PubMed  Google Scholar 

  • Bertolino A, Kumra S, Callicott JH et al. (1998b) Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am J Psychiatry 155:1376–1383

    CAS  PubMed  Google Scholar 

  • Block W, Karitzky J, Traber F et al. (1998) Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements [see comments]. Arch Neurol 55:931–936

    CAS  PubMed  Google Scholar 

  • Bluml S, Zuckerman E, Tan J et al. (1998) Proton-decoupled 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy. J Neurochem 71:1564–1576

    CAS  PubMed  Google Scholar 

  • Bluml S, Tan J, Harris K et al. (1999) Quantitative protondecoupled P-31 MRS of the schizophrenic brain in vivo. J Comput Assist Tomogr 23:272–275

    CAS  PubMed  Google Scholar 

  • Brockmann K, Pouwels PJ, Christen HJ et al. (1996) Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis. Neuropediatrics 27:242–248

    CAS  PubMed  Google Scholar 

  • Brooks DJ (1997) Advances in imaging Parkinson’s disease [editorial]. Curr Opin Neurol 10:327–331

    CAS  PubMed  Google Scholar 

  • Byrd SE, Tomita T, Palka PS et al. (1996) Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors. Part II: Clinical analysis. J Natl Med Assoc 88:717–723

    CAS  PubMed  Google Scholar 

  • Cady EB (1996) Metabolite concentrations and relaxation in perinatal cerebral hypoxic-ischemic injury. Neurochem Res 21:1043–1052

    CAS  PubMed  Google Scholar 

  • Callicott JH, Egan MF, Bertolino A et al. (1998) Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: A possible intermediate neurobiological phenotype. Biol Psychiatry 44:941–950

    CAS  PubMed  Google Scholar 

  • Caplan LR (1997) New therapies for stroke. Arch Neurol 54:1222–1224

    CAS  PubMed  Google Scholar 

  • Castillo M, Kwock L (1998) Proton MR spectroscopy of common brain tumors. Neuroimaging Clin North Am 8:733–752

    CAS  Google Scholar 

  • Cecil KM, Lenkinski RE (1998) Proton MR spectroscopy in inflammatory and infectious brain disorders. Neuroimaging Clin North Am 8:863–880

    CAS  Google Scholar 

  • Cecil KM, Lenkinski RE, Gur RE et al. (1999) Proton magnetic resonance spectroscopy in the frontal and temporallobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology 20:131–140

    CAS  PubMed  Google Scholar 

  • Cendes F, Andermann F, Dubeau F et al. (1997a) Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 49:1525–1533

    CAS  PubMed  Google Scholar 

  • Cendes F, Caramanos Z, Andermann F et al. (1997b) Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporallobe epilepsy: a series of 100 patients. Ann Neurol 42:737–746

    CAS  PubMed  Google Scholar 

  • Chang L, Ernst T, Tornatore C et al. (1997) Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 48:836–845

    CAS  PubMed  Google Scholar 

  • Chang KH, Song IC, Kim SH et al. (1998) In vivo single-voxel proton MR spectroscopy in intracranial cystic masses [see comments]. AJNR Am J Neuroradiol 19:401–405

    CAS  PubMed  Google Scholar 

  • Choe BY, Suh TS, Shinn KS et al. (1996) Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Invest Radiol 31:345–352

    CAS  PubMed  Google Scholar 

  • Choe BY, Park JW, Lee KS et al. (1998) Neuronal laterality in Parkinson’s disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy. Invest Radiol 33:450–455

    CAS  PubMed  Google Scholar 

  • Chu WI, Hetherington HP, Kuzniecky RI et al. (1998) Lateralization of human temporal lobe epilepsy by 31P NMR spectroscopic imaging at 4.1 T. Neurology 51:472–479

    CAS  PubMed  Google Scholar 

  • Clanet M, Berry I (1998) Magnetic resonance imaging in multiple sclerosis. Curr Opin Neurol 11:299–303

    CAS  PubMed  Google Scholar 

  • Clark JM, Marks MP, Adalsteinsson E et al. (1996) MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 46:223–227

    CAS  PubMed  Google Scholar 

  • Clarke CE, Lowry M, Horsman A (1997) Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson’s disease measured by proton magnetic resonance spectroscopy. Mov Disord 12:297–301

    CAS  PubMed  Google Scholar 

  • Connelly A, Van Paesschen W, Porter DA et al. (1998) Proton magnetic resonance spectroscopy in MRI-negative temporallobe epilepsy. Neurology 51:61–66

    CAS  PubMed  Google Scholar 

  • Constantinidis I, Malko JA, Peterman SB et al. (1996) Evaluation of 1H magnetic resonance spectroscopic imaging as a diagnostic tool for the lateralization of epileptogenic seizure foci. Br J Radiol 69:15–24

    CAS  PubMed  Google Scholar 

  • Cross JH, Connelly A, Jackson GD et al. (1996) Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Ann Neurol 39:107–113

    CAS  PubMed  Google Scholar 

  • Cross JH, Gordon I, Connelly A et al. (1997) Interictal 99Tc(m) HMPAO SPECT and 1H MRS in children with temporal lobe epilepsy. Epilepsia 38:338–345

    CAS  PubMed  Google Scholar 

  • Cruz CJ, Aminoff MJ, Meyerhoff DJ et al. (1997) Proton MR spectroscopic imaging of the striatum in Parkinson’s disease. Magn Reson Imaging 15:619–624

    CAS  PubMed  Google Scholar 

  • Cwik VA, Hanstock CC, Allen PS et al. (1998) Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 50:72–77

    CAS  PubMed  Google Scholar 

  • Danielsen ER, Ross B (eds) (1998) Magnetic resonance spetroscopy diagnosis of neurological diseases. Marcel Dekker, New York Basel

    Google Scholar 

  • Davie CA, Barker GJ, Thompson AJ et al. (1997) 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiplesclerosis. J Neurol Neurosurg Psychiatry 63:736–742

    CAS  PubMed  Google Scholar 

  • Davie C (1998) The role of spectroscopy in parkinsonism [editorial]. Mov Disord 13:2–4

    CAS  PubMed  Google Scholar 

  • Deicken RF, Zhou L, Schuff N et al. (1997) Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophr Res 27:65–71

    CAS  PubMed  Google Scholar 

  • Deicken RF, Zhou L, Schuff N et al. (1998) Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol Psychiatry 43:483–488

    CAS  PubMed  Google Scholar 

  • De Stefano N, Matthews PM, Fu L et al. (1998) Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121:1469–1477

    PubMed  Google Scholar 

  • Doyle VL, Barton SJ, Griffiths JR (1999) P-31 and H-1 MRS of human cancer. Curr Sci 76:772–776

    Google Scholar 

  • Dubowitz DJ, Bluml S, Arcinue E et al. (1998) MR of hypoxic encephalopathy in children after near drowning: correlation with quantitative proton MR spectroscopy and clinical outcome. AJNR Am J Neuroradiol 19:1617–1627

    CAS  PubMed  Google Scholar 

  • Duc CO, Trabesinger AH, Weber OM et al. (1998) Quantitative H-1 MRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magn Reson Imaging 16:969–979

    CAS  PubMed  Google Scholar 

  • Duncan JS (1997) Imaging and epilepsy. Brain 120:339–377

    PubMed  Google Scholar 

  • Ellis CM, Lemmens G, Williams SC et al. (1997) Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson’s disease: a proton magnetic resonance spectroscopy study. Neurology 49:438–444

    CAS  PubMed  Google Scholar 

  • Ellis CM, Simmons A, Andrews C et al. (1998) A proton magnetic resonance spectroscopic study in ALS: Correlation with clinical findings. Neurology 51:1104–1109

    CAS  PubMed  Google Scholar 

  • Ende GR, Laxer KD, Knowlton RC et al. (1997) Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 202:809–817

    CAS  Google Scholar 

  • Engelbrecht V, Rassek M, Gartner J et al. (1997a) The value of new MRI techniques in adrenoleukodystrophy. Pediatr Radiol 27:207–215

    CAS  PubMed  Google Scholar 

  • Engelbrecht V, Rassek M, Huismann J et al. (1997b) MR and proton MR spectroscopy of the brain in hyperhomocysteinemia caused by methylenetetrahydrofolate reductase deficiency. AJNR Am J Neuroradiol 18:536–539

    CAS  PubMed  Google Scholar 

  • Ernst T, Chang L, Melchor R et al. (1997) Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 203:829–836

    CAS  PubMed  Google Scholar 

  • Falini A, Calabrese G, Origgi D et al. (1996) Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives. J Neurol 243:706–714

    CAS  PubMed  Google Scholar 

  • Falini A, Calabrese G. Filippi M et al. (1998) Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. AJNR Am J Neuroradiol 19:223–229

    CAS  PubMed  Google Scholar 

  • Federico F, Simone IL, Conte C et al. (1996) Prognostic significance of metabolic changes detected by proton magnetic resonance spectroscopy in ischaemic stroke. J Neurol 243:241–247

    CAS  PubMed  Google Scholar 

  • Federico F, Simone IL, Lucivero V et al. (1997a) Proton magnetic resonance spectroscopy in Parkinson’s disease and atypical parkinsonian disorders. Mov Disord 12:903–909

    CAS  PubMed  Google Scholar 

  • Federico F, Simone IL, Lucivero V et al. (1997b) Proton magnetic resonance spectroscopy in Parkinson’s disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 62:239–242

    CAS  PubMed  Google Scholar 

  • Fu L, Matthews PM, De Stefano N et al. (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121:103–113

    PubMed  Google Scholar 

  • Fujimoto T, Nakano T, Takano T et al. (1996) Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia. Biol Psychiatry 40:14–18

    CAS  PubMed  Google Scholar 

  • Fukuzako H, Fukuzako T, Takeuchi K et al. (1996) Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms. Prog Neuropsychopharmacol Biol. Psychiatry 20:629–640

    CAS  PubMed  Google Scholar 

  • Furuya S, Naruse S, Ide M et al. (1997) Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method. NMR Biomed 10:25–30

    CAS  PubMed  Google Scholar 

  • Gadian DG, Leonard JV (1996) The role of magnetic resonance spectroscopy in the investigation of lactic acidosis and inborn errors of energy metabolism. J Inherit Metab Dis 19:548–552

    CAS  PubMed  Google Scholar 

  • Gadian DG, Isaacs EB, Cross JH et al. (1996) Lateralization of brain function in childhood revealed by magnetic resonance spectroscopy. Neurology 46:974–977

    CAS  PubMed  Google Scholar 

  • Ganesan V, Johnson A, Connelly A et al. (1997) Guanidinoacetate methyltransferase deficiency: new clinical features. Pediatr Neurol 17:155–157

    CAS  PubMed  Google Scholar 

  • Garcia PA, Laxer KD, van-der Grond J et al. (1997) Correlation of seizure frequency with N-acetyl-aspartate levels determined by IH magnetic resonance spectroscopic imaging. Magn Reson Imaging 15:475–478

    CAS  PubMed  Google Scholar 

  • Geissler A, Lock G, Frund R et al. (1997) Cerebral abnormalities in patients with cirrhosis detected by proton magneticresonance spectroscopy and magnetic resonance imaging. Hepatology 25:48–54

    CAS  PubMed  Google Scholar 

  • Gideon P, Rosenbaum S, Sperling B et al. (1999) MR-visible brain water content in human acute stroke. Magn Reson Imaging 17:301–304

    CAS  PubMed  Google Scholar 

  • Gillard JH, Barker PB, van Zijl PC et al. (1996) Proton MR spectroscopy in acute middle cerebral artery stroke. AJNR Am J Neuroradiol 17:873–886

    Google Scholar 

  • Girard N, Wang ZJ, Erbetta A et al. (1998) Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children. Neuroradiology 40:121–125

    CAS  PubMed  Google Scholar 

  • Giroud M, Walker P, Bernard D et al. (1996) Reduced brain Nacetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis. Neurol Res 18:241–24

    CAS  PubMed  Google Scholar 

  • Gonzalez RG, Guimaraes AR, Moore GJ et al. (1996) Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease. Alzheimer Dis Assoc Disord 10:46–52

    CAS  PubMed  Google Scholar 

  • Goodkin K, Wilkie FL, Concha M et al. (1997) Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates. Neuroimaging Clin North Am 7:561–579

    CAS  Google Scholar 

  • Gotsis ED, Fountas K, Kapsalaki E et al. (1996) In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors. Anticancer Res 16:1565–1567

    CAS  PubMed  Google Scholar 

  • Grand S, Esteve F, Remy C et al. (1997) Proton magnetic resonance spectroscopy: a metabolic approach of cerebral tumors and their follow-up after external radiation therapy. Rev Med Interne 18:865–875

    CAS  PubMed  Google Scholar 

  • Gredal O, Rosenbaum S, Topp S et al. (1997) Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 48:878–881

    CAS  PubMed  Google Scholar 

  • Groenendaal F., van-der Grond J., van Haastert I.C. et al. (1996) Findings in cerebral proton spin resonance spectroscopy in newborn infants with asphyxia, and psychomotor development. Ned Tijdschr Geneeskd 140:255–259

    CAS  PubMed  Google Scholar 

  • Gupta RK, Roy R, Dev R et al. (1996) Finger printing of Mycobacterium tuberculosis in patients with intracranial tuberculomas by using in vivo, ex vivo, and in vitro magnetic resonance spectroscopy. Magn Reson Med 36:829–833

    CAS  PubMed  Google Scholar 

  • Gupta RK, Roy R (1999) Magnetic resonance imaging and spectroscopy of intracranial tuberculomas. Curr Sci 76:783–788

    Google Scholar 

  • Hagberg G (1998) From magnetic resonance spectroscopy to classification of tumors. A review of pattern recognition methods. NMR Biomed 11:148–156

    CAS  PubMed  Google Scholar 

  • Hajek M, Dezortova M, Komarek V (1998) 1H MR spectroscopy in patients with mesial temporal epilepsy. MAGMA 7:95–114

    CAS  PubMed  Google Scholar 

  • Hanrahan JD, COX IJ, Edwards AD et al. (1998) Persistent increases in cerebral lactate concentration after birth asphyxia. Pediatr Res 44:304–311

    CAS  PubMed  Google Scholar 

  • Harada M, Miyoshi H, Ootsuka H et al. (1997) Accuracy and clinical utility of quantitative proton magnetic resonance spectroscopy (MRS) on phantom and chronic cerebral ischemia.Nippon Igaku Hoshasen Gakkai Zasshi 57:487–492

    CAS  PubMed  Google Scholar 

  • Harrison MJ, Newman SP, Hall CM et al. (1998) Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study. J Neurol Neurosurg Psychiatry 65:301–307

    CAS  PubMed  Google Scholar 

  • Haseler LJ, Sibbitt WL, Mojtahedzadeh HN et al. (1998) Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during orallactulose therapy. AJNR Am J Neuroradiol 19:1681–1686

    CAS  PubMed  Google Scholar 

  • Heimberg C, Komoroski RA, Lawson WB et al. (1998) Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Res 83:105–115

    CAS  PubMed  Google Scholar 

  • Heun R, Schlegel S, Graf MM et al. (1997) Proton magnetic resonance spectroscopy in dementia of Alzheimer type. Int J Geriatr Psychiatry 12:349–358

    CAS  PubMed  Google Scholar 

  • Hinsberger AD, Williamson PC, Carr TJ et al. (1997) Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia. J Psychiatry Neurosci 22:111–117

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hirsch JA, Lenkinski RE, Grossman RI (1996) MR spectroscopy in the evaluation of enhancing lesions in the brain in multiple sclerosis. AJNR Am J Neuroradiol 17:1829–1836

    CAS  PubMed  Google Scholar 

  • Holopainen IE, Lundbom NM, Metsahonkala EL et al. (1997) Temporal lobe pathology in epilepsy: proton magnetic resonance spectroscopy and positron emission tomography study. Pediatr Neurol 16:98–104

    CAS  PubMed  Google Scholar 

  • Holopainen IE, Valtonen ME, Komu ME et al. (1998) Proton spectroscopy in children with epilepsy and febrile convulsions. Pediatr Neurol 19:93–99

    CAS  PubMed  Google Scholar 

  • Huda A, Guze BH, Thomas MA et al. (1998) Clinical correlation of neuropsychological tests with H-1 magnetic resonance spectroscopy in hepatic encephalopathy. Psychosom Med 60:550–556

    CAS  PubMed  Google Scholar 

  • Huemer M, Muehl A, Wandl VK et al. (1998) Stroke-like encephalopathy in an infant with 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. Eur J Pediatr 157:743–746

    CAS  PubMed  Google Scholar 

  • Hugg JW, Kuzniecky RI, Gilliam FG et al. (1996) Normalization of contralateral metabolic function following temporallobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol 40:236–239

    CAS  PubMed  Google Scholar 

  • Huppi PS, Barnes PD (1997) Magnetic resonance techniques in the evaluation of the newborn brain. Clin Perinatol 24:693–723

    CAS  PubMed  Google Scholar 

  • Hwang JH, Graham GD, Behar KL et al. (1996) Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain. Magn Reson Med 35:633–639

    CAS  PubMed  Google Scholar 

  • Iranzo A, Moreno A, Pujol J et al. (1999) Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS. J Neurol Neurosurg Psychiatry 66:520–523

    CAS  PubMed  Google Scholar 

  • Jackson GD, Connelly A (1996) Magnetic resonance imaging and spectroscopy. Curr Opin Neurol 9:82–88

    CAS  PubMed  Google Scholar 

  • Jarvik JG, Lenkinski RE, Saykin AJ et al. (1996) Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 13:247–253

    CAS  PubMed  Google Scholar 

  • Kaibara T, Tyson RL, Sutherland GR (1998) Human cerebral neoplasms studied using MR spectroscopy: a review. Biochem Cell Biol 76:477–486

    CAS  PubMed  Google Scholar 

  • Kalra S, Cashman NR, Genge A et al. (1998) Recovery of Nacetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 9:1757–1761

    CAS  PubMed  Google Scholar 

  • Kamada K, Houkin K, Iwasaki Y et al. (1997) Metabolic and neurological patterns in chronic cerebral infarction: a single-voxel 1H-MR spectroscopy study. Neuroradiology 39:560–565

    CAS  PubMed  Google Scholar 

  • Kattapong VJ, Brooks WM, Wesley MH et al. (1996) Proton magnetic resonance spectroscopy of vascular-and Alzheimer-type dementia. Arch Neurol 53:678–680

    CAS  PubMed  Google Scholar 

  • Kegeles LS, Humaran TJ, Mann JJ (1998) In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol Psychiatry 44:382–398

    CAS  PubMed  Google Scholar 

  • King D, Batuch GH (1998) Magnetic resonance imaging and temporal lobe epilepsy. Acta Neurol Scand 98:217–223

    CAS  PubMed  Google Scholar 

  • Kizu O, Naruse S, Furuya S et al. (1998) Application of proton chemical shift imaging in monitoring of gamma knife radiosurgery on brain tumors. Magn Reson Imaging 16:197–204

    CAS  PubMed  Google Scholar 

  • Knowlton RC, Laxer KD, Ende G et al. (1997) Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol 42:829–837

    CAS  PubMed Central  PubMed  Google Scholar 

  • Korenke GC, Pouwels PJ, Frahm J et al. (1996) Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients. Pediatr Neurol 15:103–107

    CAS  PubMed  Google Scholar 

  • Kostler H (1998) Proton magnetic resonance spectroscopy in portal-systemic encephalopathy. Metab Brain Dis 13:291–301

    CAS  PubMed  Google Scholar 

  • Kugel H, Heindel W, Roth B et al. (1998) Proton MR spectroscopy in infants with cerebral energy deficiency due to hypoxia and metabolic disorders. Acta Radiol 39:701–710

    CAS  PubMed  Google Scholar 

  • Kuzniecky R (1997) Magnetic resonance and functional magnetic resonance imaging: tools for the study of human epilepsy. Curr Opin Neurol 10:88–91

    CAS  PubMed  Google Scholar 

  • Kuzniecky R, Hugg JW, Hetherington H et al. (1998) Relative utility of lH spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology 51:66–71

    CAS  PubMed  Google Scholar 

  • Lam WW, Wang ZJ, Zhao H et al. (1998) IH MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis. Neuroradiology 40:315–323

    CAS  PubMed  Google Scholar 

  • Landtblom AM, Sjoqvist L, Soderfeldt B et al. (1996) Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis-ringlike appearances in acute plaques. Acta Radiol 37:278–287

    CAS  PubMed  Google Scholar 

  • Laubenberger J, Haussinger D, Bayer S et al. (1996) HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 199:805–810

    CAS  PubMed  Google Scholar 

  • Laubenberger I, Haussinger D, Bayer S et al. (1997) Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis [see comments]. Gastroenterology 112:1610–1616

    CAS  PubMed  Google Scholar 

  • Lauriero F, Federico F, Rubini G et al. (1996) 99Tcm-HMPAO SPET and 1H-MRS (proton magnetic resonance spectroscopy) in patients with ischaemic cerebral infarction. Nucl Med Commun 17:140–146

    CAS  PubMed  Google Scholar 

  • Laxer K.D. (1997) Clinical applications of magnetic resonance spectroscopy. Epilepsia 38 Suppl 4:S13–S17

    Google Scholar 

  • Lazareff JA, Bockhorst KH, Curran I et al. (1998) Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging. Neurosurgery 43:809–817

    CAS  PubMed  Google Scholar 

  • Lim KO, Adalsteinsson E, Spielman D et al. (1998) Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry 55:346–352

    CAS  PubMed  Google Scholar 

  • Lopez VD, Lenkinski RE, Frank I (1997) Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci USA 94:9854–9859

    Google Scholar 

  • Lorek AK, Penrice JM, Cady EB et al. (1996) Cerebral energy metabolism in isovaleric acidaemia. Arch Dis Child Fetal Neonatal Ed 74:F211–F213

    CAS  PubMed  Google Scholar 

  • Lu D, Pavlakis SG, Frank Y et al. (1996) Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology 199:423–428

    CAS  PubMed  Google Scholar 

  • Lu D, Margouleff C, Rubin E et al. (1997) Temporal lobe epilepsy: correlation of proton magnetic resonance spectroscopy and 18F-fluorodeoxyglucose positron emission tomography. Magn Reson Med 37:18–23

    CAS  PubMed  Google Scholar 

  • McClure RJ, Keshavan MS, Pettegrew JW (1998) Chemical and physiologic brain imaging in schizophrenia. Psychiatr Clin North Am 21:93–122

    CAS  PubMed  Google Scholar 

  • MacKay S, Ezekiel F, Di SV et al. (1996) Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology 198:537–545

    CAS  PubMed Central  PubMed  Google Scholar 

  • Mader I, Roser W, Hagberg G et al. (1996) Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. MAGMA 4:139–150

    CAS  PubMed  Google Scholar 

  • Maldonado X, Alonso J, Giralt J et al. (1998) 31 Phosphorus magnetic resonance spectroscopy in the assessment of head and neck tumors. Int J Radiat Oncol Biol Phys 40:309–312

    CAS  PubMed  Google Scholar 

  • Marcus CD, Taylor RS, Sargentoni J et al. (1998) 1H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities. Metab Brain Dis 13:123–136

    CAS  PubMed  Google Scholar 

  • Martin E, Buchli R, Ritter S et al. (1996) Diagnostic and prognostic value of cerebral 31 P magnetic resonance spectroscopy in neonates with perinatal asphyxia. Pediatr Res 40:749–758

    CAS  PubMed  Google Scholar 

  • Matthews PM, Pioro E, Narayanan S et al. (1996) Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 119:715–722

    PubMed  Google Scholar 

  • Matthews PM, De Stefano N, Narayanan S et al. (1998) Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 18:327–336

    CAS  PubMed  Google Scholar 

  • Mathews VP, Barker PB, Blackband SI et al. (1995) Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy. AIR Am J Roentgenol 165:633–638

    CAS  Google Scholar 

  • Meyerhoff DJ, Bloomer C, Cardenas V et al. (1999) Elevated subcortical choline metabolites in cognitively and clinicallyc asymptomatic HIV + patients. Neurology 52:995–1003

    CAS  PubMed  Google Scholar 

  • Miller DH, Albert PS, Barkhof F et al. (1996) Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol 39:6–16

    CAS  PubMed  Google Scholar 

  • Miller DH, Grossman RI, Reingold SC et al. (1998) The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121:3–24

    PubMed  Google Scholar 

  • Moller HE, Weglage J, Wiedermann D et al. (1997) Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo. Brain Res 778:329–337

    CAS  PubMed  Google Scholar 

  • Moller HE, Weglage J, Wiedermann D et al. (1998) Bloodbrain barrier phenylalanine transport and individual vulnerability in phenylketonuria. J Cereb Blood Flow Metab 18:1184–1191

    CAS  PubMed  Google Scholar 

  • Moller HE, Vermathen P, Lentschig MG et al. (1999) Metabolic characterization of AIDS dementia complex by spectroscopic imaging. I Magn Reson Imaging 9:10–18

    CAS  Google Scholar 

  • Morgan MY (1996) Noninvasive neuroinvestigation in liver disease. Semin Liver Dis 16:293–314

    CAS  PubMed  Google Scholar 

  • Morishita H, Naruse S, Furuya S et al. (1997) Evaluation of cerebral ischemia with metabolic image by using 3D-CSIcomparing with SPECT and PET. Nippon Rinsho 55:1762–1767

    CAS  PubMed  Google Scholar 

  • Nagele T, Seeger U, Pereira P et al. (1999) Proton magnetic resonance spectroscopy to monitor the concentration changes of cerebral metabolites after TIPS implantation. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 170:298–303

    CAS  PubMed  Google Scholar 

  • Narayana PA, Doyle TJ, Lai D et al. (1998) Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 43:56–71

    CAS  PubMed  Google Scholar 

  • Negendank WG, Sauter R, Brown TR et al. (1996) Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84:449–458

    CAS  PubMed  Google Scholar 

  • Novotny EJ, Hyder F, Shevell M et al. (1999) GABA changes with vigabatrin in the developing human brain. Epilepsia 40:462–466

    CAS  PubMed  Google Scholar 

  • Paley M, Cozzone PJ, Alonso J et al. (1996) A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Hum Retroviruses 12:213–222

    CAS  PubMed  Google Scholar 

  • Pan JW, Hetherington HP, Vaughan JT et al. (1996) Evaluation of multiple sclerosis by 1 H spectroscopic imaging at 4.1 T. Magn Reson Med 36:72–77

    CAS  PubMed  Google Scholar 

  • Parnetti L, Tarducci R, Presciutti O et al. (1997) Proton magnetic resonance spectroscopy can differentiate Alzheimer’s disease from normal aging. Mech Ageing Dev 97:9–14

    CAS  PubMed  Google Scholar 

  • Pavlakis SG, Kingsley PB, Kaplan GP et al. (1998) Magnetic resonance spectroscopy: use in monitoring MELAS treatment. Arch Neurol 55:849–852

    CAS  PubMed  Google Scholar 

  • Pavlakis SG, Lu D, Frank Y et al. (1998) Brain lactate and Nacetylaspartate in pediatric AIDS encephalopathy. AINR Am J Neuroradiol 19:383–385

    CAS  Google Scholar 

  • Penrice J, Cady EB, Lorek A et al. (1996) Proton magnetic resonance spectroscopy of the brain in normal preterm and term infants, and early changes after perinatal hypoxia-ischemia. Pediatr Res 40:6–14

    CAS  PubMed  Google Scholar 

  • Pettegrew JW, Klunk WE, Panchalingam K et al. (1997) Magnetic resonance spectroscopic changes in Alzheimer’s disease. Ann NY Acad Sci 826:282–306

    CAS  PubMed  Google Scholar 

  • Petroff OA, Rothman DL, Behar KL et al. (1996) The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 39:95–99

    CAS  PubMed  Google Scholar 

  • Petroff OA, Mattson RH, Behar KL et al. (1998) Vigabatrin increases human brain homo carnosine and improves seizure control. Ann Neurol 44:948–952

    CAS  PubMed  Google Scholar 

  • Petroff OA, Hyder F, Mattson RH et al. (1999a) Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy [see comments]. Neurology 52:473–478

    CAS  PubMed  Google Scholar 

  • Petroff OAC, Rothman DL, Behar KL et al. (1999b) Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures. Seizure 8:120–127

    CAS  PubMed  Google Scholar 

  • Pietz J, Kreis R, Schmidt H et al. (1996) Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 201:413–420

    CAS  PubMed  Google Scholar 

  • Pietz J, Kreis R, Rupp A et al. (1999) Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Investig 103:1169–1178

    CAS  PubMed  Google Scholar 

  • Pioro EP (1997) MR spectroscopy in amyotrophic lateral sclerosis/motor neuron disease. J Neurol Sci 152 Suppl 1:S49–S53

    Google Scholar 

  • Potwarka JJ, Drost DJ, Williamson PC et al. (1999) A H-Idecoupled P-31 chemical shift imaging study of medicated schizophrenic patients and healthy controls. Biol Psychiatry 45:687–693

    CAS  PubMed  Google Scholar 

  • Pouwels PJ, Kruse B, Korenke GC et al. (1998) Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy. Neuropediatrics 29:254–264

    CAS  PubMed  Google Scholar 

  • Prost R, Haughton V, Li SJ (1997) Brain tumors: localized HI MR spectroscopy at 0.5 T. Radiology 204:235–238

    CAS  PubMed  Google Scholar 

  • Rajanayagam V, Grad J, Krivit W et al. (1996) Proton MR spectroscopy of childhood adrenoleukodystrophy. AJNR Am J Neuroradiol 17:1013–1024

    CAS  PubMed  Google Scholar 

  • Rajanayagam V, Balthazor M, Shapiro EG et al. (1997) Proton MR spectroscopy and neuropsychological testing in adrenoleukodystrophy. AJNR Am J Neuroradiol 18:1909–1914

    CAS  PubMed  Google Scholar 

  • Remy C, Grand S, Lai ES et al. (1995) 1H MRS of human brain abscesses in vivo and in vitro. Magn Reson Med 34:508–514

    CAS  PubMed  Google Scholar 

  • Rooney WD, Goodkin DE, Schuff N et al. (1997) 1H MRSI of normal appearing white matter in multiple sclerosis. Mult Scler 3:231–237

    CAS  PubMed  Google Scholar 

  • Rooney WD, Miller RG, Gelinas D et al. (1998) Decreased Nacetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 50:1800–1805

    CAS  PubMed  Google Scholar 

  • Rose SE, de-Zubicaray GI, Wang D et al. (1999) A 1H MRS study of probable Alzheimer’s disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn Reson Imaging 17:291–299

    CAS  PubMed  Google Scholar 

  • Ross BD Danielsen ER Bluml S (1996) Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy-Dig Dis 14 Suppl 1:30–3

    Google Scholar 

  • Saliba E, Barantin L, Akoka S et al. (1997) Circulation and cerebral metabolism in neonatal hypoxia-ischemia. J Gynecol Obstet Biol Reprod Paris 26:465–469

    CAS  PubMed  Google Scholar 

  • Salvan AM, Vion DJ, Confort GS et al. (1997a) Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res Hum Retroviruses 13:1055–1066

    CAS  PubMed  Google Scholar 

  • Salvan AM, Vion DJ, Confort GS et al. (1997b) Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times. Invest Radiol 32:485–495

    CAS  PubMed  Google Scholar 

  • Salvan AM, Lamoureux S, Michel G et al. (1998) Localized proton magnetic resonance spectroscopy of the brain in children infected with human immunodeficiency virus with and without encephalopathy. Pediatr Res 44:755–762

    CAS  PubMed  Google Scholar 

  • Sarchielli P, Presciutti O, Pelliccioli GP et al. (1999) Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain 122 Part 3:513–521

    Google Scholar 

  • Sarchielli P, Presciutti O, Tarducci R et al. (1998) IH-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-la: results of a preliminary study. J Neurol Neurosurg Psychiatry 64:204–212

    CAS  PubMed  Google Scholar 

  • Saunders DE, Howe FA, van-den Boogaart A et al. (1997) Discrimination of metabolite from lipid and macromolecule resonances in cerebral infarction in humans using short echo proton spectroscopy. J Magn Reson Imaging 7:1116–1121

    CAS  PubMed  Google Scholar 

  • Schiepers C, Van Hecke P, Vandenberghe R et al. (1997) Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis. Mult Scler 3:8–17

    CAS  PubMed  Google Scholar 

  • Seitz D, Grodd W, Schwab A et al. (1998) MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis. AJNR Am J Neuroradiol 19:1373–1377

    CAS  PubMed  Google Scholar 

  • Shimizu H, Kumabe T, Tominaga T et al. (1996) Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 17:737–747

    CAS  PubMed  Google Scholar 

  • Shioiri T, Hamakawa H, Kato T et al. (1996) Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: a preliminary report. Schizophr Res 22:19–26

    CAS  PubMed  Google Scholar 

  • Schuff N, Amend D, Ezekiel F et al. (1997) Changes of hippocampal N-acetyl aspartate and volume in Alzheimer’s disease. A proton MR spectroscopic imaging and MRI study. Neurology 49:1513–1521

    CAS  PubMed  Google Scholar 

  • Schuff N., Amend D.L., Meyerhoff D.J. et al. (1998) Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology 207:91–102

    CAS  PubMed Central  PubMed  Google Scholar 

  • Schulze A, Hess T, Wevers R et al. (1997) Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism [see comments]. J Pediatr 131:626–631

    CAS  PubMed  Google Scholar 

  • Schurmann M, Engelbrecht V, Lohmeier K et al. (1997) Cerebral metabolic changes in biotinidase deficiency. J Inherit Metab Dis 20:755–760

    CAS  PubMed  Google Scholar 

  • Simone IL, Federico F, Tortorella C et al. (1998) Localised 1HMR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 64:516–523

    CAS  PubMed  Google Scholar 

  • Sitoh YY, Tien RD (1998) Neuroimaging in epilepsy. J Magn Reson Imaging 8:277–288

    CAS  PubMed  Google Scholar 

  • Speck O, Thiel T, Hennig J (1996) Grading and therapy monitoring of astrocytomas with 1H-spectroscopy: preliminary study. Anticancer Res 16:1581–1585

    CAS  PubMed  Google Scholar 

  • Sperl W, Felber S, Skladal D et al. (1997) Metabolic stroke in carbamyl phosphate synthetase deficiency. Neuropediatrics 28:229–234

    CAS  PubMed  Google Scholar 

  • Stanley JA, Williamson PC, Drost DJ et al. (1996) An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophr Bull 22:597–609

    CAS  PubMed  Google Scholar 

  • Stanley JA, Cendes F, Dubeau F et al. (1998) Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy. Epilepsia 39:267–273

    CAS  PubMed  Google Scholar 

  • Stockier S, Hanefeld F (1997) Guanidinoacetate methyltransferase deficiency: a newly recognized inborn error of creatine biosynthesis. Wien Klin Wochenschr 109:86–88

    Google Scholar 

  • Sutton LN, Wang ZJ, Wehrli SL et al. (1997) Proton spectroscopy of suprasellar tumors in pediatric patients. Neurosurgery 41:388–394

    CAS  PubMed  Google Scholar 

  • Taylor JS, Langston JW, Reddick WE et al. (1996) Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 36:1251–1261

    CAS  PubMed  Google Scholar 

  • Taylor JS, Ogg RJ, Langston JW (1998) Proton MR spectroscopy of pediatric brain tumors. Neuroimaging Clin North Am 8:753–779

    CAS  Google Scholar 

  • Taylor RS, Turjanski N, Bhattacharya S et al. (1999) A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson’s disease. Metab Brain Dis 14:45–55

    Google Scholar 

  • Tedeschi G, Bertolino A, Lundbom N et al. (1996) Cortical and subcortical chemical pathology in Alzheimer’s disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology 47:696–704

    CAS  PubMed  Google Scholar 

  • Tedeschi G, Litvan I, Bonavita S et al. (1997a) Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson’s disease and corticobasal degeneration. Brain 120:1541–1552

    PubMed  Google Scholar 

  • Tedeschi G, Lundbom N, Raman R et al. (1997b) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516–524

    CAS  PubMed  Google Scholar 

  • Thomas MA, Huda A, Guze B et al. (1998a) Cerebral 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy. AJR Am J Roentgenol 171:1123–1130

    CAS  PubMed  Google Scholar 

  • Thomas MA, Ke Y, Levitt J et al. (1998b) Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia. J Magn Reson Imaging 8:841–846

    CAS  PubMed  Google Scholar 

  • Thompson JE, Castillo M, Kwock L et al. (1998) Usefulness of proton MR spectroscopy in the evaluation of temporal lobe epilepsy. AJR Am J Roentgenol 170:771–776

    CAS  PubMed  Google Scholar 

  • Tien RD, Lai PH, Smith JS et al. (1996) Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJR Am J Roentgenol 167:201–209

    CAS  PubMed  Google Scholar 

  • Tomoi M, Kimura H, Yoshida M et al. (1997) Alterations of lactate (+lipid) concentration in brain tumors with in vivo hydrogen magnetic resonance spectroscopy during radiotherapy. Invest Radiol 32:288–296

    CAS  PubMed  Google Scholar 

  • Tourbah A, Stievenart JL, Iba ZM et al. (1996) In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis. J Neuroradiol 23:49–55

    CAS  PubMed  Google Scholar 

  • Tourbah A, Stievenart JL, Iba ZM et al. (1997) Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter. Arch Neurol 54:586–592

    CAS  PubMed  Google Scholar 

  • Tracey I, Carr CA, Guimaraes AR et al. (1996) Brain cholinecontaining compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study [published erratum appears in Neurology 1996 Jun;46(6):1787]. Neurology 46:783–788

    CAS  PubMed  Google Scholar 

  • Tzika AA, Vigneron DB, Dunn RS et al. (1996) Intracranial tumors in children: small single-voxel proton MR spectroscopy using short-and long-echo sequences. Neuroradiology 38:254–263

    CAS  PubMed  Google Scholar 

  • van der Grond J, Balm R, Klijn CJ et al. (1996) Cerebral metabolism of patients with stenosis of the internal carotid artery before and after endarterectomy. J Cereb Blood Flow Metab 16:320–326

    PubMed  Google Scholar 

  • van der Grond J, Gerson JR, Laxer KD et al. (1998) Regional distribution of interictal 31P metabolic changes in patients with temporal lobe epilepsy. Epilepsia 39:527–536

    PubMed Central  PubMed  Google Scholar 

  • van der Grond J, Mali WP (1998) Multifunctional magnetic resonance imaging of cerebrovascular disease. Eur Radiol 8:726–738

    PubMed  Google Scholar 

  • van der Grond J, van-Everdingen KJ, Eikelboom BC et al. (1999) Assessment of borderzone ischemia with a combined MR imaging-MR angiography-MR spectroscopy protocol. J Magn Reson Imaging 9:1–9

    PubMed  Google Scholar 

  • van-der Knaap M, Bakker HD, Valk J (1998) MR imaging and proton spectroscopy in 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency. AJNR Am J Neuroradiol 19:378–382

    PubMed  Google Scholar 

  • Vermathen P, Ende G, Laxer KD et al. (1997) Hippocampal Nacetylaspartate in neocortical epilepsy and mesial temporallobe epilepsy. Ann Neurol 42:194–199

    CAS  PubMed  Google Scholar 

  • Vion DJ, Salvan AM, Confort GS et al. (1998) Brain proton magnetic resonance spectroscopy. Indications for diagnosis and follow-up of HIV-related encephalopathy in the adult. Presse Med 27:1398–1405

    Google Scholar 

  • Volz HP, Rzanny R, Rossger G et al. (1998) 31 Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics-a study including 50 patients and 36 controls. Biol Psychiatry 44:399–404

    CAS  PubMed  Google Scholar 

  • Waldrop SM, Davis PC, Padgett CA et al. (1998) Treatment of brain tumors in children is associated with abnormal MR spectroscopic ratios in brain tissue remote from the tumor site [see comments]. AJNR Am J Neuroradiol 19:963–970

    CAS  PubMed  Google Scholar 

  • Wang ZJ, Zimmerman RA (1998) Proton MR spectroscopy of pediatric brain metabolic disorders. Neuroimaging Clin North Am 8:781–807

    CAS  Google Scholar 

  • Wardlaw JM, Marshall I, Wild J et al. (1998) Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke 29:1618–1624

    CAS  PubMed  Google Scholar 

  • Weber OM, Verhagen A, Duc CO et al. (1999) Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography. Magn Reson Imaging 17:417–425

    CAS  PubMed  Google Scholar 

  • Wilkinson ID, Lunn S, Miszkiel KA et al. (1997a) Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS. J Neurol Neurosurg Psychiatry 63:477–482

    CAS  PubMed  Google Scholar 

  • Wilkinson ID, Miller RF, Miszkiel KA et al. (1997b) Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection. AIDS 11:289–295

    CAS  PubMed  Google Scholar 

  • Woermann FG, McLean MA, Bartlett PA et al. (1999) Short echo time single-voxel IH magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol 45:369–376

    CAS  PubMed  Google Scholar 

  • Yoshino E, Ohmori Y, Imahori Y et al. (1996) Irradiation effects on the metabolism of metastatic brain tumors: analysis by positron emission tomography and IH-magnetic resonance spectroscopy. Stereotact Funct Neurosurg 66 Suppl 1:240–259

    Google Scholar 

  • Young IR, Cecil Charles H (eds) (1996) MR spectroscopy-clinical applications and techniques. Martin Dunitz, London

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University Hospitals, Herestraat 49, 3000, Leuven, Belgium

    Paul Van Hecke Md, PhD

Authors
  1. Paul Van Hecke Md, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, University Hospitals K.U.L., Herestraat 49, 3000, Leuven, Belgium

    Philippe Demaerel MD, PhD (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Van Hecke, P. (2001). Clinical Magnetic Resonance Spectroscopy. In: Demaerel, P. (eds) Recent Advances in Diagnostic Neuroradiology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56662-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56662-2_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63003-3

  • Online ISBN: 978-3-642-56662-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation